Evidence map›Paper›PMID 31979272›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Eu-Doped Citrate-Coated Carbonated Apatite Luminescent Nanoprobes for Drug Delivery.

Ylenia Jabalera, Francesca Oltolina, Maria Prat, Concepcion Jimenez-Lopez, Jorge F Fernández-Sánchez, Duane Choquesillo-Lazarte, Jaime Gómez-Morales

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Quenching of the EuNanomaterials (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ylenia JabaleraDepartamento de Microbiología, Facultad de Ciencias, Universidad de Granada, Campus de Fuentenueva s/n, 18002 Granada, Spain.
Francesca OltolinaDepartamento de Microbiología, Facultad de Ciencias, Universidad de Granada, Campus de Fuentenueva s/n, 18002 Granada, Spain.
Maria PratDipartimento di Scienze della Salute, Università del Piemonte Orientale "A. Avogadro", Via Solaroli 17, 28100 Novara, Italy.
Concepcion Jimenez-LopezDepartamento de Microbiología, Facultad de Ciencias, Universidad de Granada, Campus de Fuentenueva s/n, 18002 Granada, Spain.
Jorge F Fernández-SánchezDepartment of Analytical Chemistry, Faculty of Sciences, University of Granada, Avda. Fuentenueva s/n, 18071 Granada, Spain.
Duane Choquesillo-LazarteLaboratorio de Estudios Cristalográficos, IACT-CSIC-Universidad de Granada, Avda. Las Palmeras, 4, 18100 Armilla, Spain.
Jaime Gómez-MoralesLaboratorio de Estudios Cristalográficos, IACT-CSIC-Universidad de Granada, Avda. Las Palmeras, 4, 18100 Armilla, Spain.
Universidad de Granada · ESConsejo Superior de Investigaciones Científicas · ESUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

Agencia Estatal de Investigación PGC2018-102047-B-I00European Regional Development Fund PGC2018-102047-B-I00Ministerio de Economía, Industria y Competitividad, Gobierno de España CGL2016-76723Ministerio de Economía, Industria y Competitividad, Gobierno de España FPU16_04580
6 · The paper itself

Abstract

In the field of Nanomedicine, there is an increasing demand for new inorganic nanophosphors with low cytotoxicity and efficient loading-release ability of drugs for applications in bioimaging and drug delivery. This work assesses the potentiality of matured Eu-doped citrate-coated carbonated apatite nanoparticles to be used as theranostic platforms, for bioimaging, as luminescent nanoprobes, and for drug delivery applications, using Doxorubicin as a model drug. The drug adsorption isotherm fits the Langmuir-Freundlich (LF) model, showing that the Eu:cit-cAp nanoparticles can carry a maximum of 0.29 ± 0.02 mg Doxo mg Eu:cit-cAp

Indexed as

adsorption isothermcytotoxicitydesorptionDoxorubicinEu-doped citrate-nanoapatitesluminescence

Identifiers

PMID31979272
PMCPMC7074876
OpenAlexW3001087945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.